But there is no prohibition on you auditing the good performer at the same rate as the bad performer?
Bob Casey
The Public Record
Robert P. Casey is a United States Senator from Pennsylvania, having served since January 4, 2007. A member of the Democratic Party, he has focused on a range of issues including healthcare, education, and economic development. Throughout his tenure, Casey has been an advocate for policies aimed at improving access to healthcare and supporting working families. He has also been involved in efforts to address climate change and promote job growth in Pennsylvania.
Are those two entities, under the law, treated the same? Are they audited at the same frequency?
I believe it's a matter of basic justice and fairness, but it does have the additional benefit of lifting all boats at the same time.
I would like to speak today about the importance of Federal investment in biomedical research. There are many reasons to invest in biomedical research, but the two most important reasons are very simple: biomedical research saves lives…
I do not know if any of the other witnesses want to say something about either of those before I move on.
I rise this evening to make some brief comments regarding a judicial nominee we voted on yesterday--one of two--Judge Luis Restrepo from Philadelphia, from the southeastern corner of Pennsylvania. I rise tonight because my train was late…
I am honored to join my fellow Senators as we remember our friend and colleague Senator Frank Lautenberg. A dedicated public servant, Frank proudly represented New Jersey almost continuously from 1982 until his death. Long before reaching…
I have a question that I am going to ask all of you, but I start with a line--I know it is not the best way to summarize testimony.
Price control for patented, lifesaving drugs, I think, is necessary, and it is an experiment that has been tried by every other country in the world.
I would just remind the Senator that I did write that there are a lot of very good, positive provisions in the Affordable Care Act, but they do not attack the price issue.
I think that, as the article suggests, there should be all kinds of interferences in the marketplace, because it is not a free marketplace.
Thank you, Mr. Chairman. We want to thank the members of the panel for being here, for your testimony and your scholarship.
I agree that empowering people to make better decisions about their health care is the first step in really transforming our health care system.
I know we are going to be voting in a matter of minutes on two judicial nominees for the Eastern District of Pennsylvania, which is the eastern side of our State. Obviously, these appointments are critically important to justice and…
I move to the second part of my remarks, which is to talk about two of our judicial nominees who will be coming before the Senate today. Both of these nominees will be voted on today to be members of the United States District Court for…
I rise to address two issues this morning, but starting with the issue that is confronting us here on the Senate floor. It is a great challenge, but it is also a great opportunity; that is, immigration. The opportunity we have to come…
Ms. Graves and the other panelists, we are grateful for your testimony here.
That is just wrong. It defies common sense, and that is right at the heart of our bill, to amend Federal law to make sure that, in every corner of the country, child victims of sex trafficking are considered as victims of abuse and neglect.
One of the most inspirational parts of your testimony is that you have figured out a way to take what happened to you yesterday and inspire others for tomorrow.





